Literature DB >> 22483424

Adhesion family of G protein-coupled receptors and cancer.

Hsi-Hsien Lin1.   

Abstract

The adhesion-class G protein-coupled receptors (adhesion-GPCRs) constitute the second largest GPCR sub-family in humans. Adhesion-GPCRs are defined by the chimeric structure of an unusually large extracellular cell-adhesion domain and a GPCR-like seven-pass transmembrane domain. Adhesion-GPCRs are hence expected to display both cellular adhesion and signaling functions in many biological systems. Adhesion-GPCRs are normally expressed in the central nervous, immune, and reproductive systems in a cell type- or tissue-restricted fashion. However, aberrant expression of distinct adhesion-GPCR molecules has been identified in various human cancers with some of the receptors closely associated with cancer development. Tumor-associated adhesion-GPCRs are thought to involve in tumorigenesis by affecting the growth of tumor cells, angiogenesis, tumor cell migration, invasion and metastasis either positively or negatively. Furthermore, some adhesion-GPCRs are considered potential biomarkers for specific types of cancers. In this review article, the expressional characteristics and functional role of cancer-associated adhesion-GPCRs are discussed in depth.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22483424     DOI: 10.4103/2319-4170.106170

Source DB:  PubMed          Journal:  Chang Gung Med J        ISSN: 2072-0939


  13 in total

Review 1.  G protein-coupled receptors as oncogenic signals in glioma: emerging therapeutic avenues.

Authors:  A E Cherry; N Stella
Journal:  Neuroscience       Date:  2014-08-24       Impact factor: 3.590

2.  Gpr110 deficiency decelerates carcinogen-induced hepatocarcinogenesis via activation of the IL-6/STAT3 pathway.

Authors:  Benting Ma; Junjie Zhu; Juan Tan; Yulei Mao; Lingyun Tang; Chunling Shen; Hongxing Zhang; Ying Kuang; Jian Fei; Xiao Yang; Zhugang Wang
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

Review 3.  Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer.

Authors:  Nijiro Nohata; Yusuke Goto; J Silvio Gutkind
Journal:  J Hum Genet       Date:  2016-10-13       Impact factor: 3.172

4.  GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancer.

Authors:  Raksha R Bhat; Puja Yadav; Debashish Sahay; Dharmendra K Bhargava; Chad J Creighton; Sahar Yazdanfard; Ahmed Al-Rawi; Vikas Yadav; Lanfang Qin; Sarmistha Nanda; Vidyalakshmi Sethunath; Xiaoyong Fu; Carmine De Angelis; Vihang A Narkar; C Kent Osborne; Rachel Schiff; Meghana V Trivedi
Journal:  Breast Cancer Res Treat       Date:  2018-03-24       Impact factor: 4.872

Review 5.  Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.

Authors:  Orit Jacobson; Xiaoyuan Chen
Journal:  Pharmacol Rev       Date:  2013-09-24       Impact factor: 25.468

Review 6.  Adhesion G-protein-coupled receptors: elusive hybrids come of age.

Authors:  Julia Simundza; Pamela Cowin
Journal:  Cell Commun Adhes       Date:  2013-11-14

Review 7.  The role of epidermal growth factor-like module containing mucin-like hormone receptor 2 in human cancers.

Authors:  Michael Safaee; Michael E Ivan; Michael C Oh; Taemin Oh; Eli T Sayegh; Gurvinder Kaur; Matthew Z Sun; Orin Bloch; Andrew T Parsa
Journal:  Oncol Rev       Date:  2014-04-01

8.  Cancer Cell Mechanics: Adhesion G Protein-coupled Receptors in Action?

Authors:  Nicole Scholz
Journal:  Front Oncol       Date:  2018-03-13       Impact factor: 6.244

9.  Activation of Adhesion GPCR EMR2/ADGRE2 Induces Macrophage Differentiation and Inflammatory Responses via16/Akt/MAPK/NF-κB Signaling Pathways.

Authors:  Kuan-Yu I; Yi-Shu Huang; Ching-Hsun Hu; Wen-Yi Tseng; Chia-Hsin Cheng; Martin Stacey; Siamon Gordon; Gin-Wen Chang; Hsi-Hsien Lin
Journal:  Front Immunol       Date:  2017-04-03       Impact factor: 7.561

10.  Adhesion G protein-coupled receptor, ELTD1, is a potential therapeutic target for retinoblastoma migration and invasion.

Authors:  Jonathan Guihurt Santiago; Neikelyn Burgos-Tirado; Daniella Dorta Lafontaine; José C Mendoza Sierra; Roberto Herrera Camacho; Clara M Vecchini Rodríguez; Vanessa Morales-Tirado; Jacqueline Flores-Otero
Journal:  BMC Cancer       Date:  2021-01-11       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.